Key facts
- Viestar (Suzhou)’s last known valuation is $19.1M (Jan 2017).
- It has raised $22.7M; the latest was Later Stage VC ($14.0M) in Nov 2025.
- Notable investors include SND Ventures Group, Northern Light Venture Capital, Shenzhen Yifeng Investment Management Enterprise, Insight Capital (Taicang), Wuhan Changfei Industrial Fund Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Viestar (Suzhou)
- ·The full record, as it builds
Funding rounds
No funding rounds for Viestar (Suzhou) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Viestar (Suzhou)
Manufacturer of optoelectronic medical equipment and devices intended to provide medical professionals with advanced diagnosis and treatment tools. The company offers development and market expansion of the probe-type laser confocal microendoscope, thereby enabling medical professionals to improve early disease diagnosis technology and medical effects.
- Sector
- Healthcare
- HQ
- Ezhou, China
- Founded
- 2014
- Employees
- 21
- Website
- biopsee.cn/
- Ownership
- Privately Held (backing)
Viestar (Suzhou) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Viestar (Suzhou) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Viestar (Suzhou) in its N-PORT filings yet. We sweep new filings monthly.